Skip to main content
. 2019 May 20;28(1):28–32. doi: 10.1136/ejhpharm-2019-001893

Table 1.

Population characteristics

Controls
n=544
Cases
n=136
P value
Female 432 (79.4%) 108 (79.4%)
Age (years), mean (SD) 82.3 (8.6) 82.3 (8.7) 0.934
 51–65 years 184 (33.8%) 46 (33.8%)
 66–81 years 196 (36.0%) 49 (36.0%)
 82–95 years 164 (30.1%) 41 (30.1%)
Weight (kg), mean (SD) 67.5 (13) 65 (11.61) 0.195
Height (cm), mean (SD) 155.5 (8) 152.4 (7.8) 0.033
BMI (kg/m2), mean (SD) 27.5 (4.9) 27.5 (4.9) 0.819
Referred smoking habit <0.0001
 Non-smoker/not stated 522 (96.0%) 121 (89.0%)
 Active smoker 16 (2.9%) 6 (4.4%)
 Former smoker 6 (1.1%) 9 (6.6%)
Referred alcoholic habit 0.042
 Non-drinker/not stated 482 (88.6%) 128 (94.1%)
 Light drinker 59 (10.8%) 6 (4.4%)
 Moderate drinker 3 (0.6%) 2 (1.5%)
Rheumatoid arthritis 5 (0.9%) 1 (0.7%) 0.838
Previous fracture 2 (0.4%) 58 (42.6%) <0.0001
Diabetes mellitus 123 (22.6%) 46 (33.8%) 0.007
Diabetes mellitus type 1 4 (0.7%) 0 (0.0%) 0.010
Diabetes mellitus type 2 119 (21.9%) 46 (33.8%) 0.010
Osteoporosis 13 (2.4%) 19 (14.0%) 0.000
Neoplasia 65 (11.9%) 13 (9.6%) 0.434
Hyperthyroidism 3 (0.6%) 4 (2.9%) 0.014
Malnutrition 1 (0.2%) 3 (2.2%) 0.006
Malabsorption 1 (0.2%) 0 (0.0%) 0.617
Chronic liver disease 7 (1.3%) 5 (3.7%) 0.058
Number of active prescriptions, median (25th and 75th percentiles) 3 (0/5) 8 (5/14) <0.0001
Patients with ≥4 active prescriptions 229 (42.1%) 104 (76.5%)

BMI, body mass index.